CXCR4 and neoplasm: Diffuse CXCR4 signal in the LV was increased in both groups, anti-PD-L1 and isotype Ctrl treatment, after GCV-mediated tumor elimination, on day 35, but to a lesser extent in anti-PD-L1-treated animals (Figure 5B).